News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Myeloma Paper of the Day, May 8th, suggested by Robert Orlowski
May 8, 2025, 14:27

Myeloma Paper of the Day, May 8th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Dysregulated immune proteins in plasma (SLAMF7, TNFRSF17 (BCMA), QPCT, SLAMF1, CNTN5, BAFF (TNFSF13B)) in the UK Biobank may predict myeloma up to 12 years before clinical diagnosis.”

Title: Dysregulated immune proteins in plasma in the UK Biobank predict Multiple Myeloma 12 years before clinical diagnosis

Authors: Joshua Fieggen, Anshul Thakur, Christopher C Butler, Karthik Ramasamy, Anjan Thakurta, David A Clifton, Lei Clifton.

Myeloma Paper of the Day, May 8th, suggested by Robert Orlowski

Read the Full Article in Blood Advances.

More posts featuring Robert Orlowski.

Anjan Thakurta Anshul Thakur blood advances cancer Christopher C Butler David A Clifton Joshua Fieggen Karthik Ramasamy Lei Clifton multiple myeloma Myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski
Special Coverage
Science
May 8, 2025, 14:27
Myeloma Paper of the Day, May 8th, suggested by Robert Orlowski
Blog
May 8, 2025, 14:25
WeTrials - Understanding the Path to Hope
Blog
May 8, 2025, 14:15
Sergio Cifuentes: Comparative Neoadjuvant and Adjuvant Studies in HER2-Positive Breast Cancer
Insight
May 8, 2025, 14:00
Elvina Almuradova on 2025 JAMA study linking stress sensitivity to increased lung cancer risk
Insight
May 8, 2025, 13:52
Guillermo Chantada highlights improvement in survival in Burkitt lymphoma from ROHA registry and Hospital Garrahan protocol
Blog
May 8, 2025, 13:43
Bret Baier: Special Report will be coming from U.S. Department of Health and Human Services on Fox News
Blog
May 8, 2025, 13:38
Komal Jhaveri: First Phase III Trial to Demonstrate Benefit of Enhertu in Early Breast Cancer
Blog
May 8, 2025, 13:29
Yasmine Hassan: Thrilled to Share Our Poster Presentation at This Year’s EASL Congress
Blog
May 8, 2025, 13:22
Siobhan Freeney: Breast Density Campaign Was Raised as a Commencement Matter at a Cross-party Session in Seanad
Blog
May 8, 2025, 13:09
Tinatin Alaverdashvili about ESTRO25 - "Heading back to my country full of motivation and new ideas"
Blog
May 8, 2025, 13:09
ESTRO - Barbara Jereczek-Fossa's Vision for the Society in the Years Ahead
Blog
May 8, 2025, 12:43
Amol Akhade: Topline Results From the DESTINY-Breast11 Phase 3 trial were announced by AstraZeneca and Daiichi Sankyo